OUTLOOK 2021
Annual industry ranking and forecast
Scrip 100
The full Scrip 100 data set for 2021 is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2019).
If you are a subscriber, you may download the data in Excel format.
Pfizer Holds Number One Spot And Takeda Breaks The Top 10
Takeda's acquisition of Shire fueled the company into a top 10 pharma company in the latest Scrip 100 rankings, as other mega-mergers are set to shape the leaderboard in the future.
Numbers Crunched: Reviewing Biopharma's FY 2019 Performance
The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?
Chapter sponsored by:
Pharma's Digital Transformation: How To Best Incorporate Wearables Amid An Evolving Landscape
The COVID-19 pandemic had accelerated pharma's digital transformation and spurred a restructuring of the clinical trials landscape.
The full Scrip 100 data set for 2020 is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2018).
If you are a subscriber, click here to download the data in Excel format.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.